findmyKOL

Teferi Mitiku, MD

Basic profile

University of California, Irvine

ORCIDNone on fileNPI
RegionOrange, CA · WestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2019Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Teferi Mitiku is a Cardiology physician affiliated with University of California, Irvine. OpenAlex indexes 16 publications with 588 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
16publications

Distinct works indexed by OpenAlex.

588citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
35companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

101 City Drive South
Orange, CA 92868

Telephone

714-456-3868

Provider last certified this registry record 8 Dec 2021.

View the NPPES registry record

Industry payments

35 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    76.5%
    Beta blocker24.6%
    Metoprolol Succinate42%Sotalol26%Carvedilol15%Sotalol Af6%Atenolol5%Metoprolol Tartrate4%Propranolol Hcl2%
    Part D<11 patients
    Calcium channel blocker8.7%
    Amlodipine Besylate76%Diltiazem 24hr Er (Cd)13%Diltiazem Hcl5%Diltiazem 12hr Er5%
    Part D<11 patients

    + 13 more classes in this area

  • Blood & clotting

    20%
    Factor Xa inhibitor17.5%
    Eliquis74%Xarelto26%
    Part D167 patients
    P2Y12 inhibitor1.5%
    Clopidogrel100%
    Part D34 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    3.5%
    Potassium supplement1.5%
    Potassium Chloride100%
    Part D26 patients
    SGLT2 inhibitor1.2%
    Farxiga100%
    Part D11 patients

    + 1 more class in this area

Where care is delivered (Part B)10.8% facility · 89.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”